Moreover, when GPR64 interacts with activated CD8 T-cells and effector memory CD8 T-cells, it may impair their cytotoxic functions, thereby reducing the effectiveness of immune cells in eliminating cancer cells. Here, ADGRG2 is linked to cancer.